The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies

BACKGROUND: A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, A., de Laat, M., Reiche, D., Fitzgerald, D., Sillence, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390376/
https://www.ncbi.nlm.nih.gov/pubmed/30808423
http://dx.doi.org/10.1186/s12917-019-1811-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390376/
https://www.ncbi.nlm.nih.gov/pubmed/30808423
http://dx.doi.org/10.1186/s12917-019-1811-2

Ejemplares similares